For the first-time ever, the World Health Organization has approved a malaria vaccine for widespread use on children.
The WHO on Wednesday has recommended the vaccine by British pharmaceutical company GlaxoSmithKline for use on children over five months in high-risk areas like sub-Saharan Africa.
The recommendation came after the vaccine showed positive results in a pilot program in Ghana, Kenya and Malawi.
WHO Director-General Tedros Adhanom Ghebreyesus said it was a long-awaited historic moment that could save tens of thousands of young lives each year.
Every year more than 400-thousand people die from malaria, the majority aged under 5 years old.